HomeATNM • NYSEAMERICAN
add
Actinium Pharmaceuticals Inc
Previous close
$1.31
Day range
$1.25 - $1.31
Year range
$1.10 - $10.24
Market cap
39.93M USD
Avg Volume
367.99K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.60M | -12.19% |
Net income | -11.57M | 12.87% |
Net profit margin | — | — |
Earnings per share | -0.37 | 24.49% |
EBITDA | -12.40M | 12.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 78.66M | -5.20% |
Total assets | 82.11M | -7.68% |
Total liabilities | 43.91M | -3.21% |
Total equity | 38.21M | — |
Shares outstanding | 31.20M | — |
Price to book | 1.07 | — |
Return on assets | -36.64% | — |
Return on capital | -73.60% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -11.57M | 12.87% |
Cash from operations | -11.98M | -7.64% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 4.60M | 60.91% |
Net change in cash | -7.37M | 11.12% |
Free cash flow | -9.48M | -24.09% |
About
CEO
Founded
2000
Website
Employees
37
